share_log

EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Short Interest Update

Defense World ·  Feb 1, 2023 02:13

eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 21,500 shares, an increase of 6.4% from the December 31st total of 20,200 shares. Based on an average trading volume of 14,700 shares, the short-interest ratio is presently 1.5 days.

eFFECTOR Therapeutics Trading Down 11.6 %

Shares of NASDAQ EFTRW opened at $0.14 on Wednesday. The firm's fifty day moving average is $0.14 and its two-hundred day moving average is $0.15. eFFECTOR Therapeutics has a 52-week low of $0.04 and a 52-week high of $0.73.

See Also

  • Get a free copy of the StockNews.com research report on eFFECTOR Therapeutics (EFTRW)
  • Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
  • Dividend King Sysco: Buying On The Dip
  • Is the 1,600% Rise in Genius Group Stock Justified?
  • After Further Review, Investors Liked Exxon Mobil's Earnings
  • Will Caterpillar Dig Its Way To Another Buying Opportunity?

Receive News & Ratings for eFFECTOR Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eFFECTOR Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment